Neurotorium
Neurotorium
  • Видео 35
  • Просмотров 9 237
What types of acquired language disorders occur due to stroke? - Post-stroke Language Impairments
In this video, Alexandra Z Durfee, Ph.D., discusses aphasia, a language disorder often resulting from left-hemisphere strokes, causing challenges with speaking, listening, reading, and writing.
Alexandra Z Durfee, Ph.D. also discusses the consequences of right hemisphere strokes while introducing apragmatism and highlighting the difficulties people face with non-literal language and emotional expression post-stroke.
-
Alexandra Z Durfee, PhD, CCC-SLP
Assistant Professor
Department of Speech-Language Pathology & Audiology
Towson University
Towson, Maryland, USA
-
Watch the Post-stroke Language Impairments video: How are language and communication related but separate concepts? - ruclips.net/vid...
Просмотров: 68

Видео

How are language and communication related but separate concepts? - Post-stroke Language Impairments
Просмотров 272 месяца назад
In this video, Alexandra Z Durfee, Ph.D., discusses the role of language and breaks down communication into its core components: exchanging ideas, the symbols (words) we use, their sounds, and sentence construction while highlighting the importance of motor skills for speaking or signing, and cognitive skills such as memory and attention. - Alexandra Z Durfee, PhD, CCC-SLP Assistant Professor D...
Post Stroke Cognitive Impairment - Neurobehavioral Consequences of Stroke
Просмотров 762 месяца назад
In this video, Professor Sarah Pendlebury discusses the often overlooked post-stroke cognitive impairment, emphasizing its association with dementia and the common misconceptions about its impact. Professor Pendlebury also highlights the prevalence of cognitive impairment after stroke, stating that even those without prior dementia are at risk. Professor Sarah Pendlebury underscores the importa...
Post-stroke neuropsychiatric symptoms - Neurobehavioral Consequences of Stroke
Просмотров 383 месяца назад
Listen as Professor Gillian Mead discusses the neuropsychiatric symptoms commonly experienced after a stroke. This video includes a comprehensive look at post-stroke depression, anxiety, apathy, and post-stroke fatigue. These symptoms, affecting a significant portion of stroke survivors, vary in occurrence and intensity and have a substantial impact on quality of life, social reintegration, and...
The Global Burden of Stroke - Neurobehavioral Consequences of Stroke
Просмотров 583 месяца назад
The burden of stroke has changed globally over the last 40 years: while high-income countries have seen a 42% reduction in stroke burden, low and middle-income countries, particularly in Africa, India, and Asia, have experienced a doubled burden, largely due to the rise of non-communicable diseases like hypertension, obesity, and diabetes. Professor Mayowa Owolabi introduces the 'Stroke Quadran...
Delirium as a Neurobehavioral Consequence of Stroke
Просмотров 323 месяца назад
Delirium is a complex syndrome and is common as a result of stroke. Delirium after stroke is associated with poorer outcomes, including more extended hospital stays, risk of later institutionalization, and mortality. In this video, Professor Terence Quinn discusses why it is important to identify delirium after a stroke and how it affects health outcomes. Learn about the challenges of estimatin...
Post-stroke Anxiety and Post-stroke Depression - Neurobehavioral Consequences of Stroke
Просмотров 323 месяца назад
In this video, Dr. Akin Ojagbemi, MBBS, PhD, MSc, emphasizes the global burden of neurobehavioral consequences of stroke and the distress it causes to patients and their families. The global high prevalence of post-stroke depression and post-stroke anxiety presents itself with an even higher burden in sub-Saharan Africa, attributed to inefficient acute care and a higher incidence of comorbiditi...
Unmet Medical Needs in Bipolar Disorder and The Role of Clinicians in Addressing Them
Просмотров 1063 месяца назад
In this video, Professor Christoph Correll discusses the complexities of bipolar disorder, shedding light on the real-world challenges in treatment, the critical role of clinicians, and the necessity of patient-centric approaches in psychiatry. Professor Correll emphasizes the urgent need for more refined treatment options and highlights the importance of tailoring care to an individual’s needs...
The Heterogeneity of Bipolar Disorder: From Clinical Observations to Precision Psychiatry
Просмотров 973 месяца назад
Bipolar disorder is a chronic and highly debilitating mental disorder characterized by recurrent mood episodes. A major challenge is its heterogeneous clinical presentation with diverse comorbidities and symptomatology, such as individual differences in the severity of mania, presence versus absence of mixed features, or presence versus absence of psychotic symptoms. Hanne Lie Kjærstad, Ph. D.,...
Artificial Intelligence (AI) Applications in Psychiatry
Просмотров 1434 месяца назад
Learn about the current strategies in the integration of AI in psychiatry, exploring its potential applications for diagnosis, therapy selection, and early risk identification. Emanuel Schwarz, PhD, summarizes the state-of-the-art AI applications: precision psychiatry through multimodal machine learning and advanced deep learning tools, while concluding with ethical and legal considerations. - ...
The complexities and challenges of treating Substance use disorders and other addictions
Просмотров 1275 месяцев назад
Listen as Professor David Nutt provides insights to enhance our understanding and treatment of substance use disorders and other addictions. - Chapters: 00:00 - Understand what the greatest challenges of treating substance use disorders are. 01:42 - Learn what the greatest harms from substance use disorders are globally. 02:13 - Discover what the latest advancements for treating substance use d...
Alzheimer’s disease is not synonymous with dementia
Просмотров 666 месяцев назад
Alzheimer’s disease (AD) is a complex progressive neurodegenerative disease characterized by the accumulation of Aβ plaques and tau NFTs, which are considered to result in neuronal loss, cognitive decline and dementia. To learn more about Alzheimer’s disease, explore our free educational material on Neurotorium: neurotorium.org/alzheimers-disease/
Novel and Emerging Pharmacologic Treatments for Schizophrenia
Просмотров 1817 месяцев назад
Schizophrenia has been treated for more than 70 years with dopamine receptor antagonists or partial agonists, whose efficacy is thought to be related to a reduction of postsynaptic dopamine transmission. These so-called first- and second-generation ”antipsychotics” have been foundational for the management of schizophrenia and psychosis in general, but treatment gaps remain. These include insuf...
Polygenic Scores in Psychiatry: The Example of Depression
Просмотров 1477 месяцев назад
Psychiatric disorders, like MDD, are influenced by multiple genes, revealing a notable genetic overlap with other conditions. This challenges our understanding of these disorders. This video with Dr Jasmina Mallet delves into the latest in psychiatric genetics, emphasizing the role of Polygenic Risk Scores (PRS) in predicting risk and its potential in clinical applications. - Read our full arti...
Biomarkers for the in vivo diagnosis of Alzheimer's disease
Просмотров 1568 месяцев назад
Alzheimer's disease (AD) causes gradual cognitive decline and dementia. Until recently, the definitive diagnosis of AD was based on autopsy assessments of brain amyloid-β plaques and tau neurofibrillary tangles, the defining biological features of AD. Biomarkers of amyloid-β and tau are vital for measuring AD pathology in living people and for differentiating between different neurodegenerative...
Neuroimaging Biomarkers for Schizophrenia
Просмотров 27111 месяцев назад
Neuroimaging Biomarkers for Schizophrenia
Interview with professor John Hardy | Part 2
Просмотров 1062 года назад
Interview with professor John Hardy | Part 2
Applied Biostatistics | Prof. Christoph Correll - Part 4
Просмотров 632 года назад
Applied Biostatistics | Prof. Christoph Correll - Part 4
Applied Biostatistics | Prof. Cristoph Correll - Part 3
Просмотров 412 года назад
Applied Biostatistics | Prof. Cristoph Correll - Part 3
Applied Biostatistics | Prof. Christoph Correll - Part 2
Просмотров 592 года назад
Applied Biostatistics | Prof. Christoph Correll - Part 2
Applied Biostatistics | Prof. Christoph Correll - Part 1
Просмотров 1602 года назад
Applied Biostatistics | Prof. Christoph Correll - Part 1
Depression in the workplace - Interview with professor David Nutt
Просмотров 1082 года назад
Depression in the workplace - Interview with professor David Nutt
Interview with professor John Hardy | Part 1
Просмотров 1452 года назад
Interview with professor John Hardy | Part 1
Psychopharmacological Hypothesis of Treatment Resistant Schizophrenia (TRS)
Просмотров 4552 года назад
Psychopharmacological Hypothesis of Treatment Resistant Schizophrenia (TRS)
Andreas Meyer-Lindenberg - Part 4 | Digital Health Implications for Treatment
Просмотров 542 года назад
Andreas Meyer-Lindenberg - Part 4 | Digital Health Implications for Treatment
Andreas Meyer-Lindenberg - Part 3 | Application for digital health in psychiatry
Просмотров 592 года назад
Andreas Meyer-Lindenberg - Part 3 | Application for digital health in psychiatry
Andreas Meyer-Lindenberg - Part 2 | Big data and how do we use it for artificial intelligence
Просмотров 952 года назад
Andreas Meyer-Lindenberg - Part 2 | Big data and how do we use it for artificial intelligence
Andreas Meyer-Lindenberg - Part 1 | Deep learning and machine learning
Просмотров 1322 года назад
Andreas Meyer-Lindenberg - Part 1 | Deep learning and machine learning
Professor David Nutt - Value of Treatment
Просмотров 1342 года назад
Professor David Nutt - Value of Treatment
Professor Sube Banerjee - Interview about Alzheimer's Disease
Просмотров 1012 года назад
Professor Sube Banerjee - Interview about Alzheimer's Disease

Комментарии

  • @yugenderdasari7170
    @yugenderdasari7170 Месяц назад

    good

  • @jeanpaultongeren125
    @jeanpaultongeren125 4 месяца назад

    all anti psyctotics right now are bad. They Block The Dopamine D2 receptor. Responsible for motivation and enthousiasm

  • @LalitaLunaYogini
    @LalitaLunaYogini 10 месяцев назад

    Wonderfully clearly illustrated As a person majorly impaired by both MDD and ADD this was very relevant and clarifying Bless